Provided by Tiger Trade Technology Pte. Ltd.

Nkarta

2.02
+0.10005.21%
Post-market: 2.020.00000.00%16:10 EST
Volume:607.32K
Turnover:1.22M
Market Cap:143.48M
PE:-1.45
High:2.04
Open:1.97
Low:1.95
Close:1.92
52wk High:2.74
52wk Low:1.31
Shares:71.03M
Float Shares:52.51M
Volume Ratio:0.62
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3887
EPS(LYR):-1.6030
ROE:-26.69%
ROA:-15.14%
PB:0.42
PE(LYR):-1.26

Loading ...

Nkarta Insiders Make Handsome Sum Selling Stock At US$2.06 Per Share

Simply Wall St.
·
Jan 23

Top Nkarta Executives Make Notable Move With Fresh Insider Stock Sales

TIPRANKS
·
Jan 21

Nkarta to Join Evercore Healthcare Conference in Miami

Reuters
·
Dec 02, 2025

Nkarta Q3 EPS USD -0.29

Reuters
·
Nov 20, 2025

Nkarta Is Maintained at Buy by Stifel

Dow Jones
·
Nov 12, 2025

Nkarta price target lowered to $11 from $12 at Stifel

TIPRANKS
·
Nov 11, 2025

Nkarta’s Strategic Management and Financial Strength Justify Buy Rating and $10 Target Price

TIPRANKS
·
Nov 11, 2025

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), BioLife Solutions (BLFS) and Cardiff Oncology (CRDF)

TIPRANKS
·
Nov 11, 2025

Nkarta Advances NKX019 Program Amid Financial Stability

TIPRANKS
·
Nov 11, 2025

Nkarta Q3 EPS $(0.29) Beats $(0.35) Estimate

Benzinga
·
Nov 11, 2025

BRIEF-Nkarta Q3 EPS USD -0.29

Reuters
·
Nov 11, 2025

Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights

GlobeNewswire
·
Nov 11, 2025

Nkarta to Participate in November Investor Conferences

GlobeNewswire
·
Oct 31, 2025

Nkarta, Inc. Advances CAR NK Cell Therapy Study for Immune-Mediated Diseases

TIPRANKS
·
Oct 28, 2025

Nkarta Unveils Promising NKX019 Data for B-Cell Depletion in Autoimmune Disease Models

Reuters
·
Oct 22, 2025

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting

GlobeNewswire
·
Oct 22, 2025

Nkarta to Participate in a September Investor Conference

GlobeNewswire
·
Sep 02, 2025

Nkarta Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13, 2025

Nkarta Q2 EPS $(0.31) Beats $(0.37) Estimate

Benzinga
·
Aug 13, 2025

Nkarta Inc. Reports Q2 2025 Net Loss of $23M, EPS of $0.31; Cash Reserves Expected to Fund Operations Through 2029

Reuters
·
Aug 13, 2025